CSIMarket Company Name, Ticker, Customers, else..
 
Sio Gene Therapies Inc   (NASDAQ: SIOX)
 

SIOX's Market share relative to its competitors, as of Q3 2022

As of Q3 2022 (Revenue in Millions of $)

Date modified: 2026-05-18T05:35:36+00:00




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

COMPANY NAME REVENUES
12 Months Ending
Q3 2022		 MARKET SHARE
12 Months
Q3 2022		 MARKET SHARE
MRQ
Q3 2022		 MARKET SHARE
A Quarter Before
Q2 2022
Sio Gene Therapies Inc 0.00 0.00% 0.00 % 0.00 %
Point Biopharma Global Inc 243.69 25.88% 1.11% 3.58%
Geron Corporation 195.86 20.80% 22.93% 38.18%
Bluebird Bio Inc 103.95 11.04% 15.44% 28.37%
Regenxbio Inc 87.82 9.33% 43.08% 4.71%
Spero Therapeutics Inc 61.19 6.50% 0.00% 0.19%
31 more competitors available

Sign in to see all competitors for Sio Gene Therapies Inc .

Sign In Create Free Account



SIOX's Market share relative to its competitors, as of Q3 2022 within the Major Pharmaceutical Preparations Industry
As of Q3 2022



COMPANY NAME MARKET SHARE
12 Months Ending
Q3 2022		 MARKET SHARE
12 Months Ending
Q2 2022		 MARKET SHARE
MRQ
Q3 2022		 MARKET SHARE

Q2 2022
Sio Gene Therapies Inc 0.00% 0.00% 0.00 % 0.00 %
Point Biopharma Global Inc 32.90% 0.00% 2.75% 5.52%
Geron Corporation 26.44% 35.77% 56.58% 58.81%
Spero Therapeutics Inc 8.26% 13.01% 0.00% 0.29%
Merus N v 7.64% 10.95% 11.96% 10.01%
2seventy Bio Inc 6.53% 7.38% 22.58% 3.32%
28 more companies available

Sign in to see all industry competitors for Sio Gene Therapies Inc .

Sign In Create Free Account



SIOX's Market share relative to its competitors, as of Q3 2022 within the Healthcare Sector
As of Q3 2022



COMPANY NAME MARKET SHARE
12 Months Ending
Q3 2022		 MARKET SHARE
12 Months Ending
Q2 2022		 MARKET SHARE
MRQ
Q3 2022		 MARKET SHARE

Q2 2022
Sio Gene Therapies Inc 0.00% 0.00% 0.00 % 0.00 %
Point Biopharma Global Inc 25.88% 0.00% 1.11% 3.58%
Geron Corporation 20.80% 22.88% 22.93% 38.18%
Bluebird Bio Inc 11.04% 10.44% 15.44% 28.37%
Regenxbio Inc 9.33% 21.23% 43.08% 4.71%
Spero Therapeutics Inc 6.50% 8.32% 0.00% 0.19%
31 more companies available

Sign in to see all sector competitors for Sio Gene Therapies Inc .

Sign In Create Free Account



Note: Market share is calculated based on total revenue. To get a more accurate picture of Sio Gene Therapies Inc's market divisions, geographic dispersion, segments, products, and services, visit Sio Gene Therapies Inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.